The AMARA (As Much As Reasonably Achievable) Study

Recruiting Observational Study
Liver Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
University Hospital of Patras · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Subjects with large inoperable liver tumors defined as at least 1 lesion larger than 5cm in maximum diameter. For the purposes of the present study, we define the AMARA principle in intensified regional TARE as a planned irradiated tumor dose \>200Gy by the partition model. The purpose of the study is to evaluate the safety and efficacy of Y90 high dose radioembolization for the management of larg…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \>18 yr * Both sexes eligible for study * Patients with primary or secondary liver tumors * Liver dominant disease * At least one lesion greater than 5.0 cm in maximum diameter * Life-expectancy \> 3 months * FLR \>40% or greater than 500mls * Must be able to tolerate pre-…
Contacts

Konstantinos Katsanos, Professor

+306978225019

katsanos@med.upatras.gr

CONTACT